How quickly does semaglutide reduce appetite — and what shapes the timeline?

The first few weeks: what most people notice

A question our prescribers hear most weeks goes something like this: "I've had my first injection, when will I actually feel less hungry?" If you're wondering how long it takes for semaglutide to suppress appetite, the honest answer is that the appetite signal can appear quickly, sometimes within two or three days of the first dose, but 2.5 mg (the starting strength for Wegovy) is calibrated for tolerability rather than maximum effect. Many people describe a subtle change at this stage (they reach for a snack and find they don't really want it) rather than a dramatic cut-off of hunger.

The GLP-1 receptor sits in both the gut and the brain. When semaglutide binds to it, the gut slows its emptying rate, which extends the physical sensation of fullness after eating. Simultaneously, signals in the hypothalamus damp down appetite and, for some people, reduce the pull of food cues. These two pathways reinforce each other. You can read more about the underlying biology on the Wegovy overview page.

Nausea is common in the early weeks, not as a side effect to push through, but as a sign the mechanisms are active. It typically lessens as the body adjusts, which is why the dose titration is gradual. If you want a broader sense of how long Wegovy takes to reduce appetite across the full titration schedule, that page covers the week-by-week picture in more detail.

Dose increases change the picture significantly

The progression from 0.25 mg through to 2.4 mg (or 7.2 mg for those on the newer higher-dose pen) is not simply about weight loss numbers, each step tends to deepen the appetite-suppressing effect. Clinically, this is why prescribers track how people feel at each stage rather than jumping straight to the maintenance dose. Many people find that appetite suppression at 1.7 mg or 2.4 mg feels noticeably different from the early weeks at 0.25 mg.

The STEP 1 trial, published in the New England Journal of Medicine, followed adults taking semaglutide 2.4 mg for 68 weeks alongside lifestyle support, reporting an average weight loss of around 15%. That result was achieved through the cumulative appetite reduction that builds over the titration schedule, not from a single dramatic early effect. The implication: patience with the process matters as much as starting it.

After each dose increase there is often a brief recurrence of nausea or early fullness, lasting a few days to two weeks for most people. This is normal and reflects the same mechanisms resetting at a higher intensity. For a closer look at how quickly semaglutide kicks in at each stage, that page breaks down the pharmacokinetic timeline.

Individual variation: why your timeline may differ

Not everyone feels the same change at the same point. Body weight, metabolic rate, how consistently the injection is taken, and individual receptor sensitivity all influence the experience. Some people describe a clear appetite shift from week one; others notice it more gradually over the first two months. Neither pattern means the medicine isn't working, weight loss data in the STEP programme showed that even people who lost less than 5% in the early months continued to benefit at the maintenance dose.

There is also the question of food choices. Semaglutide does not override hunger entirely, it changes the baseline. People who pair it with adequate protein and regular meals tend to report a more manageable experience than those who skip meals and then feel unexpectedly hungry. The rate of weight loss on Wegovy is shaped in part by how you work alongside the appetite change, not just by the medicine alone.

The NHS notes that semaglutide is used alongside a reduced-calorie diet and increased activity, both of which interact with how pronounced the appetite effect feels day to day. The NHS semaglutide page covers the full clinical context, including what to expect when doses are adjusted.

What this means if you're considering treatment

The decision most people are quietly making when they search this question is: "Is this worth it, will I actually feel different?" The evidence suggests yes, for most people, though the timeline is gradual rather than immediate, and the full effect comes at the maintenance dose rather than on day one. For context on how quickly Wegovy suppresses appetite compared with what people typically expect, that page addresses the gap between expectation and clinical reality directly.

These are prescription-only medicines. A prescriber decides whether semaglutide is appropriate for you (taking into account your health history, current medicines, and weight-related conditions) before any treatment begins. If you're thinking about whether to proceed, exploring your treatment options first can help frame the choice. Then, when you're ready, a free consultation with one of our GPhC-registered prescribers is the practical next step. They review every case individually, the same day, and can talk you through realistic expectations for your situation. Check your eligibility to get started.